Study examines the effects of the antimalarial drug, hydroxycloroquine, on antiphospholipid antibodies that are responsible for pregnancy complications in women with lupus and antiphospholipid syndrome.
Pregnancy Complications in Lupus: Retrospective Analysis from a U.S. Health Claims Database
The outlook for positive pregnancy outcomes for women with lupus remains bright, but data obtained from a large insurance claims database highlights the need for specific education and counseling to pregnant women with lupus as well as close collaboration between the rheumatologist and the obstetrician throughout the pregnancy. In this podcast, Paola Daly, Education and Research Program Manager for the Lupus Foundation of America, discusses an analysis of a U.S. Health Claims Database that the Foundation conducted in partnership with UCB, a Belgium based biopharmaceutical company. The data was presented during the American College of Rheumatology Annual Scientific Meeting.
Presenter: Paola Daly, Education and Research Program Manager
Recorded on: November 4, 2013
Length: 7 minutes
Dr. Eliza Chakravarty provides an overview of pregnancy and fertility issues in lupus.